All lobbying filings

CAPITOL COUNSEL LLC

Lobbying for ALNYLAM PHARMACEUTICALS, INC. · Pharmaceutical manufacturer.

Filing Registration - Amendment

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Mar 7, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Massachusetts

Official filing document

Lobbyists on this filing 2

JEFFREY CARROLL New on this filing

Previously held: Staff Director House Energy and Commerce Committee; Chief of Staff, Rep. Frank Pallone.
JOHN MARTIN New on this filing

Previously held: Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton; Legislative Assistant, Representative Tom Cotton.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Issues regarding FDA guidance on Platform Technology Platform Technology Designation Program for Drug Development.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.